Trifluoperazine
Trifluoperazine is a high-potency phenothiazine typical antipsychotic that blocks dopamine D2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular pathways, producing antipsychotic effects through reduction of dopaminergic transmission. It is used for schizophrenia, short-term treatment of generalized anxiety disorder, and nausea/vomiting, and also blocks histamine H1, muscarinic, and alpha-adrenergic receptors. Its high D2 affinity is associated with a high rate of extrapyramidal adverse effects including parkinsonism and tardive dyskinesia.
Peso Molecular
407,5000 g/mol
LogP
5,00
TPSA
35,00 Ų
Regra dos 5 de Lipinski
Aprovado
Áreas Terapêuticas
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Estrutura 2D
Cite this structure
Embed this structure
SMILES
CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
InChI
InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3
Molecular Formula
C21H24F3N3S
HBD / HBA
- / 7
Ligações Rotacionáveis
4
Átomos Pesados
28
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
Trifluoperazine is a high-potency phenothiazine typical antipsychotic that blocks dopamine D2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular pathways, producing antipsychotic effects through reduction of dopaminergic transmission. It is used for schizophrenia, short-term treatment of generalized anxiety disorder, and nausea/vomiting, and also blocks histamine H1, muscarinic, and alpha-adrenergic receptors. Its high D2 affinity is associated with a high rate of extrapyramidal adverse effects including parkinsonism and tardive dyskinesia.
Yes, Trifluoperazine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL422. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5566. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="trifluoperazine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/trifluoperazine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/trifluoperazine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/trifluoperazine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="trifluoperazine"></drugfyi-drug>